Mizolastine
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | By mouth (tablets) |
ATC code | R06AX25 (WHO) |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | 108612-45-9 |
PubChem (CID) | 65906 |
ChemSpider | 59315 |
UNII | 244O1F90NA |
KEGG | D01117 |
ChEMBL | CHEMBL94454 |
Chemical and physical data | |
Formula | C24H25FN6O |
Molar mass | 432.493 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Mizolastine (Mizollen) is a once-daily, non-sedating antihistamine. It blocks H1 receptors and is commonly fast-acting. It does not prevent the actual release of histamine from mast cells, just prevents it binding to receptors. Side effects can include dry mouth and throat.[1]
References
- ↑ "MIZOLASTINE: British National Formulary". Retrieved 2010-02-01.
This article is issued from Wikipedia - version of the 10/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.